Dcvc Bio

Multi-stage venture firmpart of DCVCSEC venture capital fund adviser· Palo Alto, Californiadcvc.com

Multi-stage venture firm, based in Palo Alto, California, reporting $1.0B of fund assets on its funds' Form ADV filings.

Composed from this organization's classification, location and filed figures.

Reported fund assets
$1.0B
sum of its funds' Form ADV filings, last 30 months
New companies, 12 mo
3
Investment team
16
Latest vintage
2024
As of · the latest observation of this organization; filed figures are as of its latest Form ADV

4 additional team members, 37 additional co-investors and affiliates, 1 additional investment, fund or LP, 5 events, 1 verified contact (1 firm phone)

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. 5 deals
    with Y Combinator

    Invests most often alongside Y Combinator (5 shared deals) and Sequoia Capital (4 shared deals).

    pair last observed on record 1 Oct 2026, not a deal date · The firms it syndicates with are the likeliest to see the same deals and to fill out its rounds.

    Measuredshared rounds and portfolio companies on recordFor Founders building a round, co-investorsCo-investors →

People to know

View all people
  • Managing Member
    Why: Named with investment responsibility
    No route on file yet
  • Managing Member
    Why: Named with investment responsibility
    No route on file yet
  • Managing Member
    Why: Named with investment responsibility
    No route on file yet

Relationship network

20 connected entities6 observed rounds2 repeat counterpartiesrounds 2018 to 2026

From financing rounds and every investor named in them, Form ADV and Form D filings, the firm's funds and team, and disclosed LP commitments in the venture capital graph. A round's amount is the size of the round, not money that moved between two investors.

Some relationships on this record are counted rather than named here. They open with the full profile.

Click any name or line for the rounds and sources behind it. Line weight is rounds together; dashed lines are inferred.

Reading the network
  • Sponsor
  • Company
  • Fund or vehicle
  • Person
›How strength and recency are read

Co-investors are read from the rounds: three or more shared rounds is a strong observed relationship, two a repeat co-investor, one a single round. Funds and people are structural. Nothing is scored that a reader cannot check.

Darker lines were active in the last 24 months or are current; lighter lines are older or undated.

How am I connected?

Name your firm, a company or a person, and DFX finds the published routes to Dcvc Bio: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.

See how you connect to Dcvc Bio

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Investing

179 companies on record, 3 new in 12 months

Investments on record

179 companies, 6 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
AgZenSeries B · Series BparticipantJustin Kern (confirmed)$10.0MunknownMar 13, 2026Fact Press release
EmpiricoForm D equity offeringunknown · boardJohn Hamer (strongly supported)$45.2M
form d sold
unknownMar 23, 2023Inference Form D
Avicenna Biosciences, Inc.Form D equity offeringunknown · boardJohn Hamer (strongly supported)$3.0M
form d sold
unknownDec 30, 2022Inference Form D

Stated thesis versus observed behaviour

6 observed deals
Stated (the firm’s website)
Sectors
not stated or not yet read
Stages
not stated or not yet read
Geography
not stated
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation
series b 100%
Stage at first entry
series b 100%
Industries, each company once
Hardware and deep tech, Software or Tech-enabled and IT services (5)Life sciences (2)Agriculture (1)Energy, utilities and infrastructure (1)Financial services (1)
lead rate 0%follow-on rate 67%new companies, 12 months 3

Team

45 current, 3 departed

Decision makers

who to call first, and why; then everyone else by function
  • John Hamer · Managing Member
    Why this person: Named with investment responsibility
  • Kiersten Stead · Managing Member
    Why this person: Named with investment responsibility
  • Matthew Ocko · Managing Member
    Why this person: Named with investment responsibility

Ranked by the role the firm or its filing states, a route on file and deals led. Every reason is read from the record, never inferred. Routes are published by the person or the firm (their bio, the team page or a filing) and are revealed on a plan; data bought from a provider is never shown, and a route printed at a firm the person has since left is held back.

Investment team

45 current, 3 departed
2 departed (kept with end dates)

Contacts

1 firm phone

1 firm phone on record, each with its source. Values open with the complete profile.

Funds and LPs

4 vehicles, 0 LPs disclosed

Funds and vehicles

4 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
Dcvc Bio III, L.P.Fund2024 adv first reportedEarly deployment$381M
Mar 31, 2026
45$0
of $400M
Sep 28, 2023
Dcvc Bio Opportunity Fund, L.P.Opportunity fund2022 adv first reportedActive deployment$125M
Mar 31, 2026
34$0
of $350M
Nov 18, 2021
Dcvc Bio II, L.P.Fund2020 form d first saleMature$289M
Mar 31, 2026
34$350M
of $350M
Aug 4, 2020

Limited partners

0 LPs, 0 disclosed commitments
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.

Known LPs and allocators

1 relationship across the firm's funds, from public pensions and the allocator graph
AllocatorTypeFundAmountDateSource
Dhanam FoundationFOUNDATIONDcvc Bio II, L.P.$1.3M
fair value on the foundation's return
reported as of Dec 31, 2024Fact IRS Form 990 / 990-PF e-file returns

Relationships across DFX

107 co-investors · on 2 other DFX graphs

Co-investors

107 counted from shared deals, for the whole firm

Compare portfolios with Y Combinator, Sequoia Capital, 137 Ventures Management, LLC or any firm. Co-investors across the market

Across DFX and the capital chainon 2 other DFX graphs · 1 capital path Show
Across DFX
  • The same institution is held on Allocators, RIA and Wealth, matched by identifier. See which records
Across the graphs

Dcvc Bio is the same institution as 2 records in Allocators and RIA and Wealth.

Allocators1RIA and Wealth1

DFX found 2 relationships across 2 datasets

Which record it is in each graph, what it is called there, and how the two were matched.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Checking your plan…

Capital chain

Dcvc Bio sits on 1 traced path of capital across the graphs.

Allocator commitments to a manager

DFX traced 1 path of capital through this record

Every record on each path, what it committed or lent, and as of when.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Derived from allocator disclosures, BDC schedules and SEC filings; confidence is the weakest hop.

Checking your plan…

Evidence and history

10 dated events, 50 observations from 3 sources

Timeline

10 dated events
  1. seen on or beforeSep 15, 2026
    Dcvc Bio: INSTITUTIONAL_VC -> MULTI_STAGE_VC (both early and growth/opportunity families, reported GAV $1,198M)
    Classification changedClassificationInference
  2. Mar 29, 2024
    Dcvc Bio III, L.P. first reported on Form ADV by Dcvc Bio (Venture Capital Fund), GAV $338,504,267
    Fund first reported on Form ADVFundsFactDcvc Bio III, L.P.Form ADV
  3. Mar 31, 2023
    Scott James (General Counsel) no longer on Schedule A of Dcvc Bio
    Person leftPeopleInferenceScott JamesForm ADV
  4. Sep 1, 2022
    Ryan T Ward joined Schedule A of Dcvc Bio as Chief Legal Officer
    Person joinedPeopleFactRyan T WardForm ADV
  5. Mar 29, 2022
    Dcvc Bio Opportunity Fund, L.P. first reported on Form ADV by Dcvc Bio (Venture Capital Fund), GAV $165,668,056
    Fund first reported on Form ADVFundsFactDcvc Bio Opportunity Fund, L.P.Form ADV

Identity and regulatory footprint

Address, phone, Form ADV filing and ownersForm ADV filed Mar 31, 2026 · 4 private fundsShow
Headquarters
Palo Alto, CAadviserinfo.sec.gov
Office address
unknownadviserinfo.sec.gov
Business phone
unknownadviserinfo.sec.gov
Website
dcvc.com
SEC adviser type
Exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
Venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Mar 31, 2026
Private funds reported
4 (4 venture capital funds)adviserinfo.sec.gov
Private fund gross assets, adviser total
$1.0Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Owners on Schedule A
JNK Capital Management, LLC (Member), owns 50% to 75%; ZNM Capital Management, LLC (Member), owns 50% to 75%

Classification history

Every classification this record has carried3 on recordShow
  1. Sep 23, 2026
    Multi-stage venture firm (confirmed, 95%)
    Both early and growth/opportunity families, reported GAV $1.0B
  2. Sep 15, 2026
    Multi-stage venture firm (confirmed, 95%)
    Both early and growth/opportunity families, reported GAV $1.2B
  3. Sep 12, 2026
    Institutional venture firm (confirmed, 95%)
    Venture manager, reported GAV $857M across 3 vehicles

Evidence

51 observations from 3 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
Why admittedVC exemption, VC funds reportedMar 31, 2026FactForm ADV
SEC exemption claimedVenture capital fund adviserMar 31, 2026FactForm ADV
SEC exemption claimedVenture capital fund adviserMar 29, 2024FactForm ADV
SEC adviser typeExempt reporting adviserMar 31, 2026FactForm ADV
SEC adviser typeExempt reporting adviserMar 31, 2026FactForm ADV
SEC adviser typeExempt reporting adviserMar 29, 2024FactForm ADV
First Form ADV filing2018-06-19Mar 31, 2026FactForm ADV
First Form ADV filing2018-06-19Mar 29, 2024FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-30Oct 1, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-29Sep 30, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-25Sep 26, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-23Sep 24, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-21Sep 23, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-22Sep 23, 2026FactForm ADV
Adv history loadedadv-hist-1Sep 12, 2026FactForm ADV
Latest Form ADV filing2026-03-31Mar 31, 2026FactForm ADV
Latest Form ADV filing2026-03-31Mar 31, 2026FactForm ADV
Latest Form ADV filing2024-03-29Mar 29, 2024FactForm ADV
SEC statusERA - ActiveMar 31, 2026FactForm ADV
SEC status effective2018-06-19Mar 31, 2026FactForm ADV
Venture share of reported funds1Mar 31, 2026FactForm ADV
Venture share of reported funds1Mar 29, 2024FactForm ADV
Business phoneMar 31, 2026FactForm ADV
Business phoneMar 29, 2024FactForm ADV
HeadquartersPalo Alto, CAMar 31, 2026FactForm ADV
HeadquartersPalo Alto, CAMar 29, 2024FactForm ADV
Office addressMar 31, 2026FactForm ADV
Office addressMar 29, 2024FactForm ADV
Legal formLimited Liability CompanyMar 31, 2026FactForm ADV
Legal formLimited Liability CompanyMar 29, 2024FactForm ADV
Private funds reported4Mar 31, 2026FactForm ADV
Private funds reported4Mar 31, 2026FactForm ADV
Private funds reported4Mar 29, 2024FactForm ADV
Private fund gross assets (reported)$1.0BMar 31, 2026FactForm ADV
Private fund gross assets (reported)$1.0BMar 31, 2026FactForm ADV
Private fund gross assets (reported)$1.2BMar 29, 2024FactForm ADV
Schedule a diffsadiff-1Mar 31, 2026FactForm ADV
Venture funds reported4Mar 31, 2026FactForm ADV
Venture funds reported4Mar 31, 2026FactForm ADV
Venture funds reported4Mar 29, 2024FactForm ADV
WebsiteMar 29, 2024FactForm ADV
How this is scored
Scores, classification basis and filing advisersMulti-stage venture firm, confirmed · 2 filing advisers share this firmShow
Importance
38
elevated
Active deployment
29
moderate
Emerging
0
low
Freshness
100
high
Multi-stage venture firmSEC exempt reporting adviser

Both early and growth/opportunity families, reported GAV $1.0B

One of 2 advisers that share dcvc.com; the firm is DCVC. Dcvc. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.

The inputs behind each score
importance
gav: 0.61 · funds: 0.33 · people: 0.36 · investments: 0.29 · co investors: 0
active deployment
investments 12m: 0.13 · fund raising 18m: 0 · people joined 12m: 0 · vintage within 3y: 1 · latest investment at: 2026-03-13
emerging manager
fund count: 4 · reported gav: $1.0B · first adv filing: 2018-06-19 · years since first filing: 8.3

Fits, record history and connections

scored matches for this investor, every identity change, every edge

Record history

1 identity change, 2 dated events on the change ledger, latest event first
  • Organization classification changed
    2026-09-15
  • Grouped with firm
    2026-09-12
  • Adviser's first ADV filing
    2018-06-19source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.